These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34397900)

  • 21. Prognostic value of long noncoding RNA urothelial carcinoma-associated 1 in esophageal carcinoma: A protocol for meta-analysis, TCGA data and bioinformatics analysis.
    Zhang H; Tian J; Tang J; Wang T
    Medicine (Baltimore); 2021 Apr; 100(16):e25452. PubMed ID: 33879677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between long non-coding RNA TUG1 and prognosis of patients with gastric carcinoma: A protocol for systematic review and meta-analysis.
    Xia W; Zhang Q; Li Q; Liang X
    Medicine (Baltimore); 2020 Dec; 99(49):e23522. PubMed ID: 33285765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis.
    Hao L; Du B; Xi X
    Oncol Lett; 2017 Aug; 14(2):2153-2164. PubMed ID: 28789440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway.
    Liu G; Song J; Zhao Y; Zhang L; Qin J; Cui Y
    J Recept Signal Transduct Res; 2020 Oct; 40(5):471-478. PubMed ID: 32340525
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
    Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
    Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer.
    Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M
    J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
    Lou M; Gao Z; Zhu T; Mao X; Wang Y; Yuan K; Tong J
    Oncol Lett; 2020 Feb; 19(2):1400-1408. PubMed ID: 31966070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis.
    Wang F; Wang H; Sun L; Niu C; Xu J
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C392-C401. PubMed ID: 32348176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIM59, amplified in ovarian cancer, promotes tumorigenesis through the MKP3/ERK pathway.
    Tong X; Mu P; Zhang Y; Zhao J; Wang X
    J Cell Physiol; 2020 Nov; 235(11):8236-8245. PubMed ID: 31951023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.
    Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIM59 promotes osteosarcoma progression via activation of STAT3.
    Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
    Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-4698-Trim59 axis plays a suppressive role in hepatocellular carcinoma.
    Yu D; Zhu L; Tu H; Wu L; Yang H; Xu C
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1120-1131. PubMed ID: 32114426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of oral Chinese medicine on cancer-related fatigue for lung cancer patients after chemotherapy: Protocol for systematic review and meta-analysis.
    Li P; Wang Q; Liu L; Zhou R; Liu T; Wang Y; Feng L
    PLoS One; 2022; 17(6):e0270203. PubMed ID: 35771849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Down-regulation of tripartite motif containing 59 (TRIM59) blocks the NF-κB signaling pathway and inhibits the invasion and migration of nasopharyngeal carcinoma cells].
    Wang W; Zhou L; Sun Z; Wu J; Zhao B; Cui Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 May; 38(5):419-424. PubMed ID: 35603650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIM59 deficiency promotes M1 macrophage activation and inhibits colorectal cancer through the STAT1 signaling pathway.
    Wang H; Lou J; Liu H; Liu Y; Xie B; Zhang W; Xie J; Pan H; Han W
    Sci Rep; 2024 Jul; 14(1):16081. PubMed ID: 38992114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circ_0006324 regulates cell proliferation, cell-cycle progression, apoptosis, and glycolysis of non-small cell lung cancer cells through miR-496/TRIM59 axis.
    Wang T; Zhu X; Wang K; Ding R
    J Biochem Mol Toxicol; 2023 Nov; 37(11):e23473. PubMed ID: 37545326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.
    Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C
    J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of phenotypic detection of circulating tumor cells marked by epithelial-mesenchymal transformation on the prognosis of lung cancer: A protocol for systematic review and meta-analysis.
    Ge B; Wang Y; Lei S; Zhang J
    Medicine (Baltimore); 2020 Oct; 99(44):e22960. PubMed ID: 33126365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.